Kidney stone pathophysiology: Difference between revisions
Line 26: | Line 26: | ||
** [[Hyperuricosuria]] | ** [[Hyperuricosuria]] | ||
** Biomineralization<ref name="pmid11786090">{{cite journal |vauthors=Umekawa T, Chegini N, Khan SR |title=Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells |journal=Kidney Int. |volume=61 |issue=1 |pages=105–12 |date=January 2002 |pmid=11786090 |doi=10.1046/j.1523-1755.2002.00106.x |url=}}</ref> | ** Biomineralization<ref name="pmid11786090">{{cite journal |vauthors=Umekawa T, Chegini N, Khan SR |title=Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells |journal=Kidney Int. |volume=61 |issue=1 |pages=105–12 |date=January 2002 |pmid=11786090 |doi=10.1046/j.1523-1755.2002.00106.x |url=}}</ref> | ||
The following table summarizes major mechanism of stone formation:<ref name="Moe2006">{{cite journal|last1=Moe|first1=Orson W|title=Kidney stones: pathophysiology and medical management|journal=The Lancet|volume=367|issue=9507|year=2006|pages=333–344|issn=01406736|doi=10.1016/S0140-6736(06)68071-9}}</ref><ref name="FreitagHruska1983">{{cite journal|last1=Freitag|first1=Jeffrey|last2=Hruska|first2=Keith|title=Pathophysiology of Nephrolithiasis|year=1983|pages=523–553|doi=10.1007/978-1-4613-3524-5_16}}</ref><ref name="pmid22460990">{{cite journal |vauthors=Gambaro G, Fabris A, Abaterusso C, Cosaro A, Ceol M, Mezzabotta F, Torregrossa R, Tiralongo E, Del Prete D, D'Angelo A, Anglani F |title=Pathogenesis of nephrolithiasis: recent insight from cell biology and renal pathology |journal=Clin Cases Miner Bone Metab |volume=5 |issue=2 |pages=107–9 |date=May 2008 |pmid=22460990 |doi= |url=}}</ref><ref name="Sakhaee2009">{{cite journal|last1=Sakhaee|first1=Khashayar|title=Recent advances in the pathophysiology of nephrolithiasis|journal=Kidney International|volume=75|issue=6|year=2009|pages=585–595|issn=00852538|doi=10.1038/ki.2008.626}}</ref> | The following table summarizes major mechanism of stone formation:<ref name="Moe2006">{{cite journal|last1=Moe|first1=Orson W|title=Kidney stones: pathophysiology and medical management|journal=The Lancet|volume=367|issue=9507|year=2006|pages=333–344|issn=01406736|doi=10.1016/S0140-6736(06)68071-9}}</ref><ref name="FreitagHruska1983">{{cite journal|last1=Freitag|first1=Jeffrey|last2=Hruska|first2=Keith|title=Pathophysiology of Nephrolithiasis|year=1983|pages=523–553|doi=10.1007/978-1-4613-3524-5_16}}</ref><ref name="pmid22460990">{{cite journal |vauthors=Gambaro G, Fabris A, Abaterusso C, Cosaro A, Ceol M, Mezzabotta F, Torregrossa R, Tiralongo E, Del Prete D, D'Angelo A, Anglani F |title=Pathogenesis of nephrolithiasis: recent insight from cell biology and renal pathology |journal=Clin Cases Miner Bone Metab |volume=5 |issue=2 |pages=107–9 |date=May 2008 |pmid=22460990 |doi= |url=}}</ref><ref name="Sakhaee2009">{{cite journal|last1=Sakhaee|first1=Khashayar|title=Recent advances in the pathophysiology of nephrolithiasis|journal=Kidney International|volume=75|issue=6|year=2009|pages=585–595|issn=00852538|doi=10.1038/ki.2008.626}}</ref> |
Revision as of 00:20, 21 June 2018
https://https://www.youtube.com/watch?v=uloDkeBOxGQ%7C350}} |
Kidney stone Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Kidney stone pathophysiology On the Web |
American Roentgen Ray Society Images of Kidney stone pathophysiology |
Risk calculators and risk factors for Kidney stone pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Pathophysiology
Pathogenesis
- It is understood that nephrolithiasis is the result of combination of different mechanism responsible for different types of stones:
Calcium stones
- Calcium stones are the most common type of kidney stones.[1]
- Approximately 80% of all calcium stones are calcium oxalate stones.[2][3]
- The pathophysiology of calcium stones is complex and involves:[4]
- Dietary concerns[5][6][7]
- Hypercalciuria
- Hypocitaturia
- Hyperoxaluria
- Hyperuricosuria
- Biomineralization[8]
The following table summarizes major mechanism of stone formation:[9][10][11][12]
Type of stone/Mechanism | Cause | Pathophysiology | Stone composition | Labs | |
---|---|---|---|---|---|
All stones | Low urine volume
(raises production of solutes) |
Reduced intake or increased loss of water | Renal water conservation | All stones |
|
Calcium stones | Hypercalciuria
(raises saturation of calcium salts) |
Absorptive hypercalciuria | Increased absorption in gut | Calcium oxalate or phosphate | Urine calcium concentrations >6 mmol/L (240 mg) per day |
Hyperparathyroidism | Increased absorption in gut and bone release | High concentrations of parathyroid hormone | |||
Immobilization | Bone resorption | High concentrations of vitamin D | |||
Excess of sodium in the diet | Sodium-induced physiological renal calcium leak. Possible component of gut hyperabsorption | Urine sodium concentrations >200 mmol/L per day | |||
Excess of protein or acid in diet | Protein-induced bone loss and renal leak. | ||||
Range of monogenic disorders | Bone loss, gut hyperabsorption, and renal leak in various combinations | ||||
Hypocitraturia
(raises levels of ionised calcium and reduces inhibitor activity against calcium salts) |
Renal tubular acidosis (distal type) | Renal defense of acid-base balance | Calcium phosphate |
| |
High acid load (absence of detectable acidemia) | Physiological hypocitraturia | Calcium oxalate or phosphate |
| ||
Hyperoxaluria
(raises saturation of calcium oxalate) |
Excess of oxalate in diet | Increased delivery of luminal oxalate | Calcium oxalate | Urine oxalate concentrations >70·7 mmol/L per day | |
Bowel pathology | Reduced formation of luminal calcium and calcium-oxalate complex | ||||
Increased production of endogenous oxalate | Primary hyperoxaluria (type 1 and type 2) | ||||
Hyperuricosuria
(sodium urate precipitation causes crystallization of calcium salts) |
High purine intake | Raised production and urinary excretion of sodium and urate |
| ||
Myeloproliferative diseases | |||||
Enzymatic defects | Urine uric acid concentrations >600 mg per day | ||||
Uricosuric drugs | Hypouricaemia | ||||
Genetic primary renal leak | Increased excretion of uric acid | ||||
Uric acid stones | Low urine pH or hyperuricosuria |
|
Titrates urate to poorly soluble uric acid | Uric acid | Urine pH <5·5 |
Cystine stones | Cystinuria | Congenital mutations of dibasic aminoacid transporter subunits rBAT and b0+AT | Renal leak of basic aminoacids | Cystine | Urine concentrations of cystine high (>150 μmol/mmol creatinine) |
Infection stones | Urinary tract infection | Urea-splitting organisms | Production of ammonium and bicarbonate from urea |
|
Genetics
- Nephrolithiasis can be passed on to following generations due to rare causes of hypercalciuria:
- Hereditary distal renal tubular acidosis
- Dent disease
- Bartter syndrome types III and IV
- Autosomal dominant hypocalcemic hypercalciuria
- Familial hypomagnesemia
Associated Conditions
Gross Pathology
- On gross pathology, the characteristic findings of nephrolithiasis are:
- Location = 80% unilateral, usually in calyces, pelvis or bladder
- Size=variable, 2-3 mm usually
- All stones contain an organic matrix of mucoprotein
- Shape:
- Struvite stone= staghorn calculus
-
Nephrolithiasis, Source: Wikimedia commons[13]
-
Staghorn shape of struvite stones, Source: Wikimedia commons[14]
-
Renal calculi, different shapes and sizes, Source: Wikimedia commons[15]
-
Kidney stone with a maximum dimension of 5mm, Source: Wikimedia commons[16]
Microscopic Pathology
- On microscopic histopathological analysis, the characteristic findings of nephrolithiasis are:
- Shapes of different stones/crystals are different:
- Cysteine= hexagonal
- Struvite= coffin lid shape
- Calcium oxalate= pyramid shape
- Calcium oxalate= dumbbell shape
- Uric acid= rectangular/rhomboidal
- Oxalate crystals are highlighted by polarized light
- Foreign body giant cells and macrophages are seen with the stones
- Shapes of different stones/crystals are different:
-
Type of stones. Light microscopy of urine crystals. (A) Hexagonal cystine crystal (200X); (B) coffin-lid shaped struvite crystals (200X); (C) pyramid-shaped calcium oxalate dehydrate crystals (200X); (D) dumbbell-shaped calcium oxalate monohydrate crystal (400X); (E) rectangular uric acid crystals (400X); and (F) rhomboidal uric acid crystals (400X).[17]
-
Deposits of oxalate with variable size and form; they occupy mainly distal tubules. The asterisks indicate proximal tubules, which usually do not contain these crystals, H&E seen with polarized light, X200[18]
-
Medullary interstitial urate crystal deposits in chronic nephropathy by urates as seen after Masson's trichome stain X400[19]
-
Calcium oxalate dihydrate crystals under Scanning Electron Micrograph (SEM) taken at 30 KV. Source: Wikimedia commons[20]
-
Density-dependent color scanning electron micrograph of kidney stone, Source: Wikimedia commons[21]
References
- ↑ Pak CY (December 1991). "Etiology and treatment of urolithiasis". Am. J. Kidney Dis. 18 (6): 624–37. PMID 1962646.
- ↑ Mandel NS, Mandel GS (December 1989). "Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition". J. Urol. 142 (6): 1516–21. PMID 2585627.
- ↑ Hochreiter W, Knoll T, Hess B (February 2003). "[Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi]". Ther Umsch (in German). 60 (2): 89–97. doi:10.1024/0040-5930.60.2.89. PMID 12649987.
- ↑ Messa P, Marangella M, Paganin L, Codardini M, Cruciatti A, Turrin D, Filiberto Z, Mioni G (September 1997). "Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones". Clin. Sci. 93 (3): 257–63. PMID 9337641.
- ↑ Messa P, Marangella M, Paganin L, Codardini M, Cruciatti A, Turrin D, Filiberto Z, Mioni G (September 1997). "Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones". Clin. Sci. 93 (3): 257–63. PMID 9337641.
- ↑ Trinchieri A (February 2013). "Diet and renal stone formation". Minerva Med. 104 (1): 41–54. PMID 23392537.
- ↑ Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F (July 2015). "Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group". Arch Ital Urol Androl. 87 (2): 105–20. doi:10.4081/aiua.2015.2.105. PMID 26150027.
- ↑ Umekawa T, Chegini N, Khan SR (January 2002). "Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells". Kidney Int. 61 (1): 105–12. doi:10.1046/j.1523-1755.2002.00106.x. PMID 11786090.
- ↑ Moe, Orson W (2006). "Kidney stones: pathophysiology and medical management". The Lancet. 367 (9507): 333–344. doi:10.1016/S0140-6736(06)68071-9. ISSN 0140-6736.
- ↑ Freitag, Jeffrey; Hruska, Keith (1983). "Pathophysiology of Nephrolithiasis": 523–553. doi:10.1007/978-1-4613-3524-5_16.
- ↑ Gambaro G, Fabris A, Abaterusso C, Cosaro A, Ceol M, Mezzabotta F, Torregrossa R, Tiralongo E, Del Prete D, D'Angelo A, Anglani F (May 2008). "Pathogenesis of nephrolithiasis: recent insight from cell biology and renal pathology". Clin Cases Miner Bone Metab. 5 (2): 107–9. PMID 22460990.
- ↑ Sakhaee, Khashayar (2009). "Recent advances in the pathophysiology of nephrolithiasis". Kidney International. 75 (6): 585–595. doi:10.1038/ki.2008.626. ISSN 0085-2538.
- ↑ By Amadalvarez - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=46706235
- ↑ By H. Zell [GFDL (http://www.gnu.org/copyleft/fdl.html) or CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0)], from Wikimedia Commons
- ↑ By Jakupica - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=45324355
- ↑ By RJHall - Own work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=4070842
- ↑ Han H, Segal AM, Seifter JL, Dwyer JT (July 2015). "Nutritional Management of Kidney Stones (Nephrolithiasis)". Clin Nutr Res. 4 (3): 137–52. doi:10.7762/cnr.2015.4.3.137. PMC 4525130. PMID 26251832.
- ↑ http://kidneypathology.com/Imagenes/Diabetes/Oxalato.4.w.jpg
- ↑ http://www.kidneypathology.com/English_version/Diabetes_and_others.html
- ↑ By Kempf EK - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=18036112
- ↑ By Sergio Bertazzo - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=45316797